VANGUARD GROUP INC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$197,108,000
+50.0%
8,481,433
+2.7%
0.01%
+33.3%
Q1 2018$131,418,000
-21.0%
8,254,894
+3.1%
0.01%
-14.3%
Q4 2017$166,387,000
+52.1%
8,007,068
+4.9%
0.01%
+40.0%
Q3 2017$109,361,000
-13.1%
7,631,642
+4.9%
0.01%
-16.7%
Q2 2017$125,853,000
+63.5%
7,274,717
+4.2%
0.01%
+50.0%
Q1 2017$76,990,000
-16.6%
6,980,074
+9.8%
0.00%
-20.0%
Q4 2016$92,325,000
-38.2%
6,358,456
+4.5%
0.01%
-44.4%
Q3 2016$149,370,000
+25.3%
6,084,309
+2.8%
0.01%
+28.6%
Q2 2016$119,175,000
-14.3%
5,917,325
+11.9%
0.01%
-22.2%
Q1 2016$139,025,000
-69.2%
5,286,114
+19.0%
0.01%
-70.0%
Q4 2015$451,403,000
-38.4%
4,440,755
+8.0%
0.03%
+11.1%
Q3 2015$733,262,000
-9.5%
4,110,676
+12.7%
0.03%
-50.9%
Q2 2015$810,157,000
+26.0%
3,646,892
+12.7%
0.06%
+25.0%
Q1 2015$642,909,000
+2584.0%
3,236,883
+1584.1%
0.04%
+2100.0%
Q4 2013$23,953,000192,2040.00%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2015
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders